“Finding the origins of human cancer”
Event details
| Date | 17.02.2022 |
| Hour | 12:15 › 13:30 |
| Speaker | Sam Behjati - Group Leader and Wellcome Trust Intermediate Clinical Fellow |
| Location |
AGORA Paternot Auditorium
Online
|
| Category | Conferences - Seminars |
| Event Language | English |
A Lola and John Grace Distinguished Lecture in Cancer Research
Dr Behjati is a Group Leader and Wellcome Trust Intermediate Clinical Fellow working across cellular genetics and cancer. He is also Honorary Consultant Paediatric Oncologist at Addenbrooke’s Hospital, both in Cambridge, UK. His research sits at the interface of cancer genomics and single cell transcriptomics. Dr Behjati’s team uses cutting edge single cell techniques to understand normal human development and how normal development relates to disease. The focus is on understanding and quantifying the nature and origins of cancer cells, particularly childhood cancers. To do this, the research combines the study of somatic genomic changes, bulk and single cell transcriptomics, and mathematical modelling of data.
Originally from Germany, Sam read medicine at Oxford, followed by academic clinical training in London and Cambridge. He joined Corpus as a Research Fellow in 2016 and provides supervisions in cancer biology. Dr Behjati undertook his doctoral studies in classical cancer genomics at Sanger.
AGORA BUILDING - PATERNOT AUDITORIUM
Originally from Germany, Sam read medicine at Oxford, followed by academic clinical training in London and Cambridge. He joined Corpus as a Research Fellow in 2016 and provides supervisions in cancer biology. Dr Behjati undertook his doctoral studies in classical cancer genomics at Sanger.
AGORA BUILDING - PATERNOT AUDITORIUM
Practical information
- Informed public
- Free
- This event is internal
Organizer
- Prof. Freddy Radtke, Director ISREC
Contact
- Lisa Smith, ISREC Administrative Assistant (please contact me to obtain the Zoom passcode for this seminar). There are a limited number of in person places in conference room SV 1717, on the basis of first come, first served - 30 places maximum. A covid vaccination QR code or certificate is required for in person access.